Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.95 USD | -1.02% | -23.53% | +5.41% |
May. 29 | HC Wainwright Starts Cognition Therapeutics With Buy Rating, $10 Price Target | MT |
May. 07 | Cognition Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Evolution of the average Target Price on Cognition Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Cognition Therapeutics, Inc.
HC Wainwright | |
Ladenburg Thalmann | |
B. Riley | |
Oppenheimer | |
Cantor Fitzgerald |
EPS Revisions
- Stock Market
- Equities
- CGTX Stock
- Consensus Cognition Therapeutics, Inc.